About This Funding Round
Nucleome Therapeutics technology uses novel molecular biology techniques that define the 3D structure of the genome and computational genomics powered by machine learning to help deliver the next generation of genetically guided therapeutics.
Unlock Comprehensive Funding Intelligence
Get access to detailed funding analysis, investor insights, company intelligence, and much more
Funding Analytics
Round size percentiles, market activity, sector trends
Company Intelligence
Growth stage analysis, funding history, investor quality
Premium Tools
Export data, save to watchlist, share analysis
What You'll Get with Membership:
Join thousands of investors, founders, and analysts who rely on Seedtable's intelligence platform
Funding Details
- Amount Raised
- $44.0M
- Funding Type
- Funding Round
- Date
- October 1, 2022